HeartBeam, a development stage company based in Santa Clara, California, focuses on advanced cardiovascular diagnostic technology and went public on October 14, 2021. They are developing proprietary VECG technology and two patented products, HeartBeam AIMI and HeartBeam AIMIGo, for cardiac disease detection and monitoring.
BEAT has been in the news recently: HeartBeam, Inc. (NASDAQ:BEAT) experienced a notable rise in stock price on Monday, with trading volume reaching 193.38 million shares, significantly higher than its average of 2.191 million. Additionally, Gainers, a relevant entity, reported a 25% increase in revenue this quarter compared to the previous year, attributed to strong sales in their leading product line.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.